临床和实验医学杂志2024,Vol.23Issue(9) :995-999.DOI:10.3969/j.issn.1671-4695.2024.09.026

不同方法联合放疗治疗薄型瘢痕疙瘩的疗效及对MMPs、HIF-1α、TGF-β1的影响

Effect of different methods combined with radiotherapy on thin keloid and influence on MMPs,HIF-1α and TGF-β1

陈向军 于丽 姚尧 吴迪 王星 李志军
临床和实验医学杂志2024,Vol.23Issue(9) :995-999.DOI:10.3969/j.issn.1671-4695.2024.09.026

不同方法联合放疗治疗薄型瘢痕疙瘩的疗效及对MMPs、HIF-1α、TGF-β1的影响

Effect of different methods combined with radiotherapy on thin keloid and influence on MMPs,HIF-1α and TGF-β1

陈向军 1于丽 2姚尧 3吴迪 4王星 5李志军5
扫码查看

作者信息

  • 1. 内蒙古医科大学研究生院 内蒙古 呼和浩特 010110;内蒙古医科大学附属肿瘤医院(内蒙古自治区肿瘤医院)整形外科 内蒙古 呼和浩特 010020
  • 2. 中国人民解放军联勤保障部队第九六九医院重症医学科 内蒙古 呼和浩特 011011
  • 3. 内蒙古医科大学附属肿瘤医院(内蒙古自治区肿瘤医院)皮肤性病科 内蒙古 呼和浩特 010020
  • 4. 内蒙古医科大学附属肿瘤医院(内蒙古自治区肿瘤医院)整形外科 内蒙古 呼和浩特 010020
  • 5. 内蒙古医科大学基础医学院人体解剖学教研室 内蒙古 呼和浩特 010110
  • 折叠

摘要

目的 探讨不同方法联合放疗治疗薄型瘢痕疙瘩的疗效及对基质金属蛋白酶(MMPs)、缺氧诱导因子-1α(HIF-1α)及转化生长因子-β1(TGF-β1)的影响.方法 回顾性选取2020年10月至2022年9月内蒙古医科大学附属肿瘤医院(内蒙古自治区肿瘤医院)整形外科收治的胸腹部瘢痕疙瘩患者62例(癡痕疙瘩数94个),依据治疗方法不同分为激光联合放疗(LCR)组(30例,瘢痕疙瘩数47个)、手术联合放疗(SCR)组(32例,瘢痕疙瘩数47个).LCR组行CO2点阵LCR,SCR组行SCR.观察两组治疗12个月后临床疗效、复发情况.比较两组治疗前、治疗12个月后的患者与观察者瘢痕评估量表(POSAS)评分、温哥华瘢痕量表(VSS)评分、瘢痕组织基质金属蛋白酶(MMP)-2、MMP-9、HIF-1α、TGF-β1等细胞因子水平的变化.结果 LCR组总有效率(93.62%)大于SCR组(76.60%),复发率(4.26%)小于SCR组(19.15%),差异均有统计学意义(P<0.05).治疗12个月后,LCR组POSAS、VSS评分分别为(23.96±2.64)、(5.28±0.54)分,均低于 SCR 组[(33.96±3.59)、(6.55±0.68)分],差异均有统计学意义(P<0.05).LCR 组瘢痕组织 MMP-2、MMP-9 及 HIF-1α、TGF-β1 表达量分别为 111.65±13.55、106.76±12.68、1.24±0.14、1.10±0.12,均低于 SCR 组(127.96±14.71、121.08±14.33、1.55±0.17、1.22±0.13),差异均有统计学意义(P<0.05).两组不良反应发生率比较(38.30%vs.46.81%),差异无统计学意义(P>0.05).结论 LCR和SCR均可改善薄型癡痕疙瘩症状,抑制瘢痕疙瘩复发,但LCR的治愈率更高,复发率更低,对瘢痕组织MMPs及HIF-1α、TGF-β1表达抑制作用更强,且安全性较高,值得临床推荐.

Abstract

Objective To study the effects of different methods combined with radiotherapy on thin keloid and the effects on matrix metal-loproteinases(MMPs),hypoxia inducible factor-1α(HIF-1α),and transforming growth factor-1β(TGF-β1).Methods A total of 62 pa-tients with thoracic and abdominal keloids(94 keloids)admitted to the Department of Plastic Surgery,Affiliated Cancer Hospital of Inner Mongolia Medical University(Inner Mongolia Autonomous Region Cancer Hospital)from October 2020 to September 2022 were selected and divided into la-ser combined with radiotherapy(LCR)group(30 cases,47 keloids)and surgery combined with radiotherapy(SCR)group(30 cases,47 ke-loids)according to different treatment methods.The LCR group received CO2 lattice LCR,and the SCR group received SCR.The clinical efficacy and recurrence rate were observed after 12 months of treatment in the two groups.Changes of patient and observer scar assessment scale(POSAS)score,Vancouver scar scale(VSS)score,cytokines such as matrix metalloproteinase(MMP)-2 and MMP-9,HIF-1α and TGF-β1 in scar tissue before and after 12 months of treatment in two groups.Results The total effective rate of LCR group was 93.62%,which was higher than that of SCR group(76.60%),and the recurrence rate was 4.26%,which was lower than that of SCR group(19.15%),the differences were statistically significant(P<0.05).After 12 months of treatment,POSAS and VSS scores in LCR group were(23.96±2.64)and(5.28±0.54)points,which were lower than those in SCR group[(33.96±3.59)and(6.55±0.68)points],the differences were statistically significant(P<0.05).The levels of MMP-2,MMP-9,HIF-1α and TGF-β1 expression in scar tissue of LCR group were 111.65±13.55,106.76±12.68,1.24±0.14,1.10±0.12,which were lower than those in SCR group(127.96±14.71,121.08±14.33,1.55±0.17,1.22±0.13),the differences were statistically significant(P<0.05).There was no statistically significant difference in the incidence of adverse reactions be-tween the two groups(38.30%vs.46.81%)(P>0.05).Conclusion LCR and SCR both improve symptoms of thin scar tissue and inhibit scar recurrence,but LCR has a higher cure rate and lower recurrence rate.It has a stronger inhibitory effect on MMPs and HIF-1α,TGF-β1 expression in scar tissue,and is safe,making it worthy of clinical recommendation.

关键词

瘢痕疙瘩/基质金属蛋白酶类/缺氧诱导因子-1,α亚基/转化生长因子-β1/手术联合放疗/激光联合放疗

Key words

Keloid/Matrix metalloproteinases/Hypoxia inducible factor 1,alpha subunit/Transforming growth factor beta1/Surgery combined with radiotherapy/Laser combined with radiotherapy

引用本文复制引用

基金项目

内蒙古自治区自然科学基金(2020LH08021)

出版年

2024
临床和实验医学杂志
首都医科大学附属北京友谊医院

临床和实验医学杂志

CSTPCD
影响因子:1.504
ISSN:1671-4695
段落导航相关论文